NFL BiosciencesXPAR:ALNFL -1.49%29 Days Payable is 128.52 as of Dec. 2025, which is 20% above its 10-year median of 106.68. GuruFocus rates XPAR:ALNFL with a GF Score™ of 29/100. The stock has 1 warning sign investors should review. Among 702 Biotechnology companies, NFL Biosciences ranks better than 52.71% on this metric.
The historical rank and industry rank for NFL Biosciences's Days Payable or its related term are showing as below:
XPAR:ALNFL'
s Days Payable Range Over the Past 10 Years
Min: 38.08 Med: 106.68 Max: 390.97
Current: 123.41
During the past 8 years, NFL Biosciences's highest Days Payable was 390.97. The lowest was 38.08. And the median was 106.68.
XPAR:ALNFL's Days Payable is ranked better than 52.71% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs XPAR:ALNFL: 123.41
NFL Biosciences's Days Payable
declined
from Dec. 2024 (193.35) to Dec. 2025 (128.52).
It may suggest that NFL Biosciencesaccelerated paying its suppliers.
NFL Biosciences Days Payable Related Terms
NFL Biosciences Days Payable Historical Data
* Premium members only.
The historical data trend for NFL Biosciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALNFL vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, NFL Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NFL Biosciences Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NFL Biosciences's Days Payable distribution charts can be found below:
* The bar in red indicates where NFL Biosciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
NFL Biosciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NFL Biosciences (XPAR:ALNFL) has a Days Payable of 128.52 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NFL Biosciences and its competitors. This is 20% above median its historical median of 106.68. Over the past decade, NFL Biosciences' Days Payable has ranged from 38.08 to 390.97. According to the industry distribution chart, NFL Biosciences ranks #332 out of 702 companies in the Biotechnology industry, placing it in the top 47.3%.
Is NFL Biosciences' Days Payable too high?
NFL Biosciences' current Days Payable of 128.52 is 20% above median its 10-year median of 106.68. Over the past 10 years, this metric has ranged from a low of 38.08 to a high of 390.97. The Biotechnology industry median Days Payable is 113.10. NFL Biosciences' value of 128.52 is 13.6% above this industry median. Based on the distribution chart, NFL Biosciences ranks #332 out of 702 companies in the Biotechnology industry, which is above the industry midpoint. Overall, NFL Biosciences has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does NFL Biosciences' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, NFL Biosciences ranks #332 out of 702 companies for Days Payable. This puts NFL Biosciences in the upper half of its industry. The industry median Days Payable is 113.10. NFL Biosciences' value of 128.52 is 13.6% above this benchmark. Historically, NFL Biosciences' own Days Payable has ranged from 38.08 to 390.97 over the past decade. While the company's 10-year median is 106.68 vs. the industry median of 113.10, NFL Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NFL Biosciences's current Days Payable of 128.52 is 13.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NFL Biosciences and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NFL Biosciences's current Days Payable is 128.52, which is 20% above median its own 10-year median of 106.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NFL Biosciences stock overvalued right now?
NFL Biosciences (XPAR:ALNFL) has a current Days Payable of 128.52. The current Days Payable is 128.52, which is 20% above median its 10-year median of 106.68 and 13.6% above the Biotechnology industry median of 113.10. NFL Biosciences' overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For NFL Biosciences (XPAR:ALNFL), the current Days Payable is 128.52 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
29GF Score
Get the complete analysis for XPAR:ALNFL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALNFL has been successfully added to your 
